MicroRNA 4265 (MIR4265)

MicroRNA 4265 (MIR4265, hsa-mir-4265) is a small, endogenous non-coding RNA classified as a microRNA. Like other microRNAs, it is likely involved in the silencing or degradation of target messenger RNAs, predominantly acting via binding to complementary sequences within their 3’ untranslated regions. MicroRNAs play central roles in gene regulatory networks across a wide range of cellular processes, including cell proliferation, differentiation, apoptosis, and responses to physiological and pathological signals. Changes in miRNA expression are well-documented in diseases such as cancer and autoimmune disorders generally, but the specific biological targets, functions, or disease implications of MIR4265 have not been described in the scientific literature or clinical resources. As such, it is not considered a validated therapeutic target or biomarker at this time[1][2][4][5].

Other names

hsa-mir-4265hsa-miR-4265MIR4265